End Stage Renal Disease on Dialysis Clinical Trial
Official title:
Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
The main purpose of the study is to determine if empagliflozin can reduce peritoneal glucose absorption in patients with end stage renal diease (ESRD) on peritoneal dialysis. This is a randomized, placebo controlled, acute crossover study of empagliflozin in an anticipated 30 chronic PD patients, with an 8 week "pre post" open label extension in all 30 patients where they will receive empagliflozin daily.
Participants will undergo three study visits, and up to 4 safety visits, over 9 weeks. At 7 AM in the first study visit, the participants will have taken 25mg empagliflozin once or matching placebo, thus producing peak plasma levels by 10 AM. One week later the participant will return for the crossed over to the alternate study drug. At the conclusion of the 2nd study visit, all participants will be provided with empagliflozin 10mg tabs to be taken daily for 56 days (8 weeks). At each study visit and safety visit, participants will undergo a PET test. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05978479 -
The Effect of Individualized Education Using the Teach-Back Method Treatment on Treatment Adherence and the Coping Skills
|
N/A | |
| Completed |
NCT06022835 -
Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis
|
N/A | |
| Completed |
NCT05540457 -
Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)
|
N/A | |
| Recruiting |
NCT04046042 -
Virtual Reality Intradialysis: Last vs. First Part of the Session
|
N/A | |
| Not yet recruiting |
NCT04527640 -
Effects of Synbiotics Supplementation on the Uremic Toxin Indoxyl Sulfate Level and Constipation in End-stage Renal Disease Patients Undergoing Hemodialysis
|
N/A | |
| Completed |
NCT05947708 -
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
|
N/A | |
| Recruiting |
NCT05735743 -
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
|
N/A | |
| Completed |
NCT04505462 -
Dietary Therapy in Dialysis Patients
|
N/A | |
| Active, not recruiting |
NCT04546958 -
Nutritional Interventions in Peritoneal Dialysis Patients With Hypoalbuminemia
|
N/A | |
| Recruiting |
NCT04286477 -
The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT
|
||
| Completed |
NCT04487301 -
A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
|
||
| Recruiting |
NCT05677555 -
Colchicine and Inflammation in Hemodialysis Patients
|
Phase 2 | |
| Completed |
NCT04789876 -
Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia
|
N/A | |
| Completed |
NCT04125537 -
Pathways Project: Kidney Supportive Care
|
||
| Suspended |
NCT05915286 -
Diuretic Use in Hemodialysis Patients With Residual Renal Function
|
Phase 4 | |
| Completed |
NCT04912050 -
EXtension of Tablo TrEatmeNt Duration Registry
|
||
| Recruiting |
NCT04360694 -
RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE)
|
N/A | |
| Recruiting |
NCT04501159 -
pH, Hypoxia and Haemodialysis
|
||
| Recruiting |
NCT05032651 -
Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients
|
N/A | |
| Completed |
NCT04806126 -
Evaluation of a Virtual Home Dialysis Mentoring Program (Home)
|